PCI had a strong presence at the Philly Builds Bio+ 3rd Annual Symposium on October 1st, 2024. John Swartley, PhD, MBA, Chief Innovation Officer at Penn, participated in a panel on the science driving innovation and commercialization, discussing emerging technologies, and Penn’s contribution to advancing Philadelphia’s bio-innovation ecosystem. Tomas Isakowitz, Program Director at PCI, also participated in a panel where he discussed fostering innovation through programs such as Penn I-Corps, which focuses on customer discovery. Five Penn I-Corps teams also presented their innovative projects, ranging from medical devices to cancer care solutions. Read more here.